Innovative Research Award
Sencan Acar
Istanbul Florence Nightingale Hospital, Turkey
| Sencan Acar |
| Affiliation |
Istanbul Florence Nightingale Hospital |
| Country |
Turkey |
| Scopus ID |
57193702255 |
| Documents |
33 |
| Citations |
127 |
| h-index |
7 |
| Subject Area |
Autoimmune Liver Diseases |
| Event |
Biotechnology Scientist Awards |
Sencan Acar is a researcher affiliated with Istanbul Florence Nightingale Hospital in Turkey whose documented scholarly profile includes research in the area of autoimmune liver diseases. The available Scopus profile records 33 documents, 127 citations, and an h-index of 7. [1] These bibliometric indicators provide a quantitative basis for considering the researcher within an academic recognition framework focused on innovative research.
Abstract
Sencan Acar is affiliated with Istanbul Florence Nightingale Hospital, Turkey, and has a documented scholarly profile associated with autoimmune liver diseases. According to the supplied Scopus author information, the profile contains 33 documents, 127 citations, and an h-index of 7. [1] The research profile is considered in relation to the Innovative Research Award at the Biotechnology Scientist Awards, with emphasis on documented scholarly activity, research continuity, and contribution to a specialized biomedical research area.
Keywords
- Sencan Acar
- Innovative Research Award
- Autoimmune Liver Diseases
- Biotechnology Research
- Biomedical Research
- Clinical Research
- Research Impact
- Biotechnology Scientist Awards
Introduction
Research concerning autoimmune liver diseases occupies an important position within contemporary hepatology and biomedical science because these disorders involve complex interactions between immune regulation, inflammation, genetics, environmental factors, and hepatic function. Scholarly work in this area can contribute to improved understanding of disease mechanisms, diagnosis, clinical characterization, and therapeutic strategies.
Within this research landscape, Sencan Acar’s documented affiliation with Istanbul Florence Nightingale Hospital and subject-area association with autoimmune liver diseases establish a clinical and biomedical context for evaluating the research profile. The available bibliometric record indicates sustained scholarly output represented by 33 documents and measurable citation activity. [1]
Research Profile
The available author information identifies Sencan Acar with Scopus Author ID 57193702255. The profile records 33 documents, 127 citations, and an h-index of 7. [1] These indicators are commonly used as descriptive measures of scholarly publication activity and citation visibility, although bibliometric indicators should be interpreted alongside the quality, relevance, originality, and broader significance of individual research outputs.
Research Contributions
The supplied research information places Acar’s scholarly activity within autoimmune liver diseases, a specialized area connecting immunology, hepatology, pathology, and clinical medicine. Research in this field may address disease classification, immunological mechanisms, diagnostic assessment, clinical outcomes, and management strategies. The available bibliometric record provides evidence of an established publication record but does not, by itself, establish the specific novelty or clinical effect of individual studies. [1]
For an innovation-focused academic recognition, relevant contributions may therefore be assessed through the originality of research questions, methodological rigor, reproducibility, publication quality, interdisciplinary relevance, and the extent to which findings advance scientific understanding or practical biomedical applications.
Publications
The supplied Scopus profile records 33 documents associated with the researcher. [1] This document count indicates a body of indexed scholarly output. A complete publication-level assessment would require examination of individual article titles, journals, publication dates, citation distributions, authorship roles, study designs, and research findings.
Because the available input does not provide a complete publication bibliography or individual DOI records, specific article titles and DOI identifiers are not attributed here. This approach avoids assigning publications or identifiers to the researcher without direct bibliographic verification.
Research Impact
The reported citation count of 127 and h-index of 7 provide quantitative indicators of the visibility of Acar’s indexed scholarly work. [1] Citation-based measures can help describe how frequently published work has been referenced by subsequent research, but they should not be interpreted as a standalone measure of scientific quality, innovation, or societal impact.
In the context of autoimmune liver diseases, research impact may also be considered through contributions to clinical knowledge, diagnostic reasoning, understanding of disease mechanisms, treatment approaches, interdisciplinary collaboration, and the translation of research findings into healthcare practice. A comprehensive evaluation would combine bibliometric evidence with qualitative assessment of the underlying publications.
Award Suitability
Acar’s documented affiliation, subject-area specialization, publication record, citation activity, and h-index provide a factual basis for consideration for an Innovative Research Award. [1] The relevance of the profile to an innovation-focused award can be further evaluated through the originality and scientific significance of the research outputs, methodological contribution, interdisciplinary value, and evidence of influence on subsequent research or clinical practice.
The Biotechnology Scientist Awards provide a recognition context for researchers whose work contributes to scientific and technological advancement. In an award assessment, bibliometric information can serve as one component of the evaluation, while the substantive content and quality of the candidate’s research should remain central to the determination.
Conclusion
Sencan Acar’s academic profile reflects documented research activity associated with autoimmune liver diseases and an affiliation with Istanbul Florence Nightingale Hospital in Turkey. The supplied Scopus information reports 33 documents, 127 citations, and an h-index of 7. [1] These indicators establish a measurable scholarly record that can support consideration for the Innovative Research Award, subject to detailed evaluation of the originality, rigor, relevance, and impact of the underlying research.
External Links
References
- Elsevier. (n.d.). Scopus author details: Sencan Acar, Author ID 57193702255. Scopus.
https://www.scopus.com/pages/authors/57193702255
- The challenge of cholecystectomy after successful choledocholithiasis extraction in elderly patients with comorbidities
https://www.scopus.com/pages/authors/57193702255